Spectralis HRA+OCT and variants with OCT Angiography Module
K-Number: K181594 · 2018-09-13
Device Summary
Frequently Asked Questions
What is the Spectralis HRA+OCT and variants with OCT Angiography Module?
Spectralis HRA+OCT and variants with OCT Angiography Module is a medical device that received FDA 510(k) clearance on 2018-09-13. The listed applicant is Heidelberg Engineering GmbH. The 510(k) number is K181594.
When did Spectralis HRA+OCT and variants with OCT Angiography Module receive FDA 510(k) clearance?
Spectralis HRA+OCT and variants with OCT Angiography Module received FDA 510(k) clearance on 2018-09-13, under 510(k) number K181594.
Who is the listed applicant for Spectralis HRA+OCT and variants with OCT Angiography Module?
The FDA 510(k) record lists Heidelberg Engineering GmbH as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Spectralis HRA+OCT and variants with OCT Angiography Module?
The FDA product code for Spectralis HRA+OCT and variants with OCT Angiography Module is OBO.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Heidelberg Engineering GmbH as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: OBO)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.